MORGAN STANLEY PLC/CALL/MERCK & CO./130/0.1/20.06.25 Share Price

Warrant

DE000MB71H83

Real-time Bid/Ask 05:46:21 08/07/2024 pm IST
1.02 EUR / 1.04 EUR +7.29% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./130/0.1/20.06.25
Current month-18.64%
1 month-20.66%
Date Price Change
08/24/08 1 +4.17%
05/24/05 0.96 +1.05%
04/24/04 0.95 -5.00%
03/24/03 1 -7.41%
02/24/02 1.08 -5.26%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 12:27 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB71H8
ISINDE000MB71H83
Date issued 06/06/2023
Strike 130 $
Maturity 20/06/2025 (347 Days)
Parity 10 : 1
Emission price 1.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.55
Lowest since issue 0.26
Spread 0.03
Spread %2.86%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus